Re:Alterations in glutamate and the experience of ego dissol...
by PragmaticPulp on Thursday May 28, 2020 @12:11PM
(#23338962)
> The profit motive would clearly prioritize finding an expensive medication that must be taken regularly and indefinitely.
The idea that pharmaceutical companies are deliberately avoiding one-time treatments is a myth.
If you assume profit is the ultimate motive, there's nothing stopping a pharmaceutical company from charging $10,000 for a long-lasting depression treatment.
It's not like pharmaceutical companies are going to stumble upon a perfect treatment and then decline to patent it.
Also, patents don't last forever. Common SSRI anti-depressants are available for $4-5/month.
The idea that pharmaceutical companies are deliberately avoiding one-time treatments is a myth.
If you assume profit is the ultimate motive, there's nothing stopping a pharmaceutical company from charging $10,000 for a long-lasting depression treatment.
It's not like pharmaceutical companies are going to stumble upon a perfect treatment and then decline to patent it.
Also, patents don't last forever. Common SSRI anti-depressants are available for $4-5/month.